Abstract
Fecal testing can only reduce colorectal cancer mortality if patients with an abnormal test result receive a follow-up colonoscopy. As part of the Strategies and Opportunities to STOP Colon Cancer in Priority Populations (STOP CRC) project, we examined factors associated with adherence to follow-up colonoscopy among patients with abnormal fecal test results. As part of STOP CRC outreach, Virginia Garcia Memorial Health Center staff distributed 1753 fecal immunochemical tests (FIT), of which 677 (39 %) were completed, and 56 had an abnormal result (8 %). Project staff used logistic regression analyses to examine factors associated with colonoscopy referral and completion. Of the 56 patients with abnormal FIT results; 45 (80 %) had evidence of a referral for colonoscopy, 32 (57 %) had evidence of a completed colonoscopy within 18 months, and 14 (25 %) within 60 days of an abnormal fecal test result. In adjusted analysis, Hispanics had lower odds of completing follow-up colonoscopy within 60 days than non-Hispanic whites (adjusted OR 0.20; 95 % CI 0.04, 0.92). Colonoscopy within 60 days trended lower for women than for men (adjusted OR 0.25; 95 % CI 0.06–1.04). Among the 24 patients lacking medical record evidence of a colonoscopy, 19 (79 %) had a documented reason, including clinician did not pursue, patient refused, and colonoscopy not indicated. No reason was found for 21 %. Improvements are needed to increase rates of follow-up colonoscopy completion, especially among female and Hispanic patients.
Similar content being viewed by others
References
US Preventive Services Task Force. (2008). Screening for colorectal cancer, Topic page. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/colorectal-cancer-screening. Accessed 5 Nov 2014.
Centers for Disease Control and Prevention. (2013). Awareness of prediabetes—United States, 2005–2010. Morbidity and Mortality Weekly Report (MMWR), 62(11), 209–212.
Wang, J., Moehring, J., Stuhr, S., & Krug, M. (2013). Barriers to colorectal cancer screening in Hispanics in the United States: An integrative review. Applied Nursing Research, 26(4), 218–224.
Otiniano, M. E., Wood, R. C., Poursani, R. S., Katerndahl, D. A., Siddiqui, S., & Nadeau, M. T. (2013). Association of knowledge, attitudes, and behaviors for colon cancer screening in Hispanic patients. Ethnicity and Disease, 23(3), 343–348.
Johnson-Kozlow, M., Roussos, S., Rovniak, L., & Hovell, M. (2009). Colorectal cancer test use among Californians of Mexican origin: Influence of language barriers. Ethnicity and Disease, 19(3), 315–322.
Day, L. W., Bhuket, T., & Allison, J. (2013). FIT testing: An overview. Current Gastroenterology Reports, 15(11), 357.
Hernandez, V., Cubiella, J., Gonzalez-Mao, M. C., Iglesias, F., Rivera, C., Iglesias, M. B., et al. (2014). Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World Journal of Gastroenterology, 20(4), 1038–1047.
Singh, H., Petersen, L. A., Daci, K., Collins, C., Khan, M., & El-Serag, H. B. (2010). Reducing referral delays in colorectal cancer diagnosis: Is it about how you ask? Quality and Safety in Health Care, 19(5), e27.
Powell, A. A., Nugent, S., Ordin, D. L., Noorbaloochi, S., & Partin, M. R. (2011). Evaluation of a VHA collaborative to improve follow-up after a positive colorectal cancer screening test. Medical Care, 49(10), 897–903.
Etzioni, D. A., Yano, E. M., Rubenstein, L. V., Lee, M. L., Ko, C. Y., Brook, R. H., et al. (2006). Measuring the quality of colorectal cancer screening: The importance of follow-up. Diseases of the Colon and Rectum, 49(7), 1002–1010.
Powell, A. A., Gravely, A. A., Ordin, D. L., Schlosser, J. E., & Partin, M. R. (2009). Timely follow-up of positive fecal occult blood tests strategies associated with improvement. American Journal of Preventive Medicine, 37(2), 87–93.
Partin, M. R., Burgess, D. J., Burgess, J. F, Jr, Gravely, A., Haggstrom, D., Lillie, S. E., et al. (2015). Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: An observational study. Cancer Epidemiology Biomarkers & Prevention, 24(2), 422–434.
Partin, M. R., Gravely, A., Gellad, Z. F., Nugent, S., Burgess, J. F., Shaukat, A., et al. (2016). Factors associated with missed and cancelled colonoscopy appointments at Veterans Health Administration facilities. Clinical Gastroenterology and Hepatology, 14(2), 259–267.
Virginia Garcia Memorial Health Center. (2014). Funding & patient demographics. http://virginiagarcia.org/who-we-are/health-center/funding-patientdemographics/. Accessed 24 Sept 2014.
Lieberman, D. A., Rex, D. K., Winawer, S. J., Giardiello, F. M., Johnson, D. A., & Levin, T. R. (2012). Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology, 143(3), 844–857.
Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51(6), 1173–1182.
Kleinbaum, D., Lawrence, K., Nizam, A., & Muller, K. (2008). Applied regression analysis and other applied multivariable analysis (4th ed.). Australia, Belmont, CA: Brooks/Cole.
Hillyer, G. C., Schmitt, K. M., Freedberg, D. E., Kramer, R. A., Su, Y., Rosenberg, R. M., et al. (2014). Fecal-based colorectal cancer screening among the uninsured in northern Manhattan. American Journal of Preventive Medicine, 47(2), 182–187.
LoConte, N. K., Weeth-Feinstein, L., Conlon, A., & Scott, S. (2013). Engaging health systems to increase colorectal cancer screening: Community-clinical outreach in underserved areas of Wisconsin. Preventing Chronic Disease, 10, E192.
Levy, B. T., Daly, J. M., Luxon, B., Merchant, M. L., Xu, Y., Levitz, C. E., et al. (2010). The “Iowa get screened” colon cancer screening program. Journal of Primary Care & Community Health, 1(1), 43–49.
Carlson, C. M., Kirby, K. A., Casadei, M. A., Partin, M. R., Kistler, C. E., & Walter, L. C. (2011). Lack of follow-up after fecal occult blood testing in older adults: Inappropriate screening or failure to follow up? Archives of Internal Medicine, 171(3), 249–256.
Dupont-Lucas, C., Dejardin, O., Dancourt, V., Launay, L., Launoy, G., & Guittet, L. (2011). Socio-geographical determinants of colonoscopy uptake after faecal occult blood test. Digestive and Liver Disease, 43(9), 714–720.
Ferrat, E., Le Breton, J., Veerabudun, K., Bercier, S., Brixi, Z., Khoshnood, B., et al. (2013). Colorectal cancer screening: Factors associated with colonoscopy after a positive faecal occult blood test. British Journal of Cancer, 109(6), 1437–1444.
Mansouri, D., McMillan, D. C., Grant, Y., Crighton, E. M., & Horgan, P. G. (2013). The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme. PLoS ONE, 8(6), e66063.
Fisher, D. A., Jeffreys, A., Coffman, C. J., & Fasanella, K. (2006). Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiology Biomarkers & Prevention, 15(6), 1232–1235.
Choi, K. S., Lee, H. Y., Jun, J. K., Shin, A., & Park, E. C. (2012). Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004–2008. Journal of Gastroenterology and Hepatology, 27(6), 1070–1077.
Morris, S., Baio, G., Kendall, E., von Wagner, C., Wardle, J., Atkin, W., et al. (2012). Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: A retrospective analysis of the NHS Bowel Cancer Screening Programme. British Journal of Cancer, 107(5), 765–771.
Miglioretti, D. L., Rutter, C. M., Bradford, S. C., Zauber, A. G., Kessler, L. G., Feuer, E. J., et al. (2008). Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Medical Care, 46(9 Suppl 1), S91–S96.
Percac-Lima, S., Grant, R. W., Green, A. R., Ashburner, J. M., Gamba, G., Oo, S., et al. (2009). A culturally tailored navigator program for colorectal cancer screening in a community health center: A randomized, controlled trial. Journal of General Internal Medicine, 24(2), 211–217.
Percac-Lima, S., Benner, C. S., Lui, R., Aldrich, L. S., Oo, S. A., Regan, N., et al. (2013). The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women. Journal of Women’s Health (Larchmt), 22(5), 426–431.
Coronado, G. D., Schneider, J. L., Sanchez, J. J., Petrik, A. F., & Green, B. (2015). Reasons for non-response to a direct-mailed FIT kit program: Lessons learned from a pragmatic colorectal-cancer screening study in a federally sponsored health center. Translational Behavioral Medicine, 5(1), 60–67.
Acknowledgments
Research reported in this publication was supported by the National Institutes of Health through the National Center for Complementary &Alternative Medicine under Award Number UH2AT007782 and the National Cancer Institute under Award Number 4UH3CA188640-02. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary & Alternative Medicine or the National Cancer Institute. Dr. Saha’s contribution to this work was supported with resources and the use of facilities at the VA Portland Health Care System.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Oluloro, A., Petrik, A.F., Turner, A. et al. Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice. J Community Health 41, 864–870 (2016). https://doi.org/10.1007/s10900-016-0165-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-016-0165-y